Shorter Duration of Dysphagia Symptoms Without Stent

This article originally appeared here.
Share this content:
Shorter Duration of Dysphagia Symptoms Without Stent
Shorter Duration of Dysphagia Symptoms Without Stent

MONDAY, Nov. 30, 2015 (HealthDay News) -- For patients undergoing laryngotracheoplasty, posterior cricoid split laryngoplasty, tracheal resection, and cricotracheal resection, dysphagia duration is shorter for those without versus those with stents, according to a study published online Nov. 19 in JAMA Otolaryngology-Head & Neck Surgery.

Christen J. Lennon, M.D., from the Vanderbilt University Medical Center in Nashville, Tenn., and colleagues reviewed the duration of postoperative dysphagia symptoms and outcomes in adult patients. Medical records of 38 patients undergoing laryngotracheoplasty, posterior cricoid split laryngoplasty, tracheal resection, and cricotracheal resection and fitting the inclusion criteria were reviewed.

The researchers found that of the 17 patients with stents placed, six, six, and five, respectively, had a suprastomal stent sewn at the top with a polypropylene suture using a horizontal mattress technique, a suprastomal stent capped with an extended Silastic thoracic T-tube segment, and either a T-tube or hood bronchial stent. While the stent was in place (up to five weeks), eight of the patients used a nasogastric feeding tube. All of the patients returned to their preoperative diet. For all patients, the mean duration of dysphagia symptoms was eight days. In patients who did not have a stent placed, the mean duration of dysphagia was 4.8 days.

"In this study of adults who underwent open airway reconstruction, all returned to their preoperative diet, but those without stents had a shorter duration of dysphagia symptoms than those with stents," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »